Everest Medicines (HKG: 01952) announced its interim results for the six months ended June 30, 2026. Everest delivered strong growth and reached an important profitability...
1. Revenue: Net Interest Income Drives Growth; Fee-Income Volatility Mirrors Broader Industry Trends
Bank of Chongqing's headline revenue figures provide a useful starting...